Cytosorbents (CTSO) Total Current Liabilities (2010 - 2026)
Cytosorbents' (CTSO) quarterly Total Current Liabilities came in at $16.3 million in Q1 2026, up 67.45% YoY from $9.7 million in Q1 2025, and up 67.92% on a QoQ basis from $9.7 million in Q4 2025.
Cytosorbents (CTSO) Total Current Liabilities (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Total Current Liabilities data on file, last reported at $16.3 million in Q1 2026.
- Quarterly Total Current Liabilities rose 67.45% year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (up 67.45% YoY) and the FY2025 annual result came in at $9.7 million, down 1.18% from the prior year.
- Total Current Liabilities advanced to $16.3 million in Q1 2026, from $9.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $16.3 million in Q1 2026 to a low of $8.3 million in Q3 2024.
- A 5-year average of $11.0 million and a median of $10.0 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities plunged 35.57% — and 2026, when it soared 67.45%.
- Tracing CTSO's Total Current Liabilities over 5 years: stood at $9.7 million in 2022, then jumped by 44.48% to $14.0 million in 2023, then decreased by 30.0% to $9.8 million in 2024, then dropped by 1.18% to $9.7 million in 2025, then soared by 67.92% to $16.3 million in 2026.
- The last three Total Current Liabilities figures came in at $16.3 million (Q1 2026), $9.7 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 24.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.02 Mn |
| Mar 31, 2026 | 16.30 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 10.11 Mn |
| Jun 30, 2025 | 9.84 Mn |
| Mar 31, 2025 | 9.74 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Jun 30, 2024 | 9.64 Mn |
| Mar 31, 2024 | 12.72 Mn |
| Dec 31, 2023 | 14.04 Mn |
| Sep 30, 2023 | 11.67 Mn |
| Jun 30, 2023 | 9.99 Mn |
| Mar 31, 2023 | 9.45 Mn |
| Dec 31, 2022 | 9.71 Mn |
| Sep 30, 2022 | 10.12 Mn |
| Jun 30, 2022 | 10.55 Mn |
| Mar 31, 2022 | 14.67 Mn |
| Dec 31, 2021 | 13.69 Mn |
| Sep 30, 2021 | 11.07 Mn |